| 000 | 01548 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515214252.0 | ||
| 264 | 0 | _c20100819 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2010.02.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJiménez-Pérez, M | |
| 245 | 0 | 0 |
_aHepatitis C virus recurrence after liver transplantation: analysis of factors related to sustained viral response. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cMar 2010 |
||
| 300 |
_a666-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 | _aLiver Transplantation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aSáez-Gómez, A B | |
| 700 | 1 | _aPérez-Daga, J A | |
| 700 | 1 | _aLozano-Rey, J M | |
| 700 | 1 | _ade la Cruz-Lombardo, J | |
| 700 | 1 | _aRodrigo-López, J M | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 42 _gno. 2 _gp. 666-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2010.02.008 _zAvailable from publisher's website |
| 999 |
_c19667778 _d19667778 |
||